TNFRSF10B and cancer: When ovarian (OVCAR-3) cancer cells were tested using DR5 targeting KMTR2-IgG1 and KMTR2-FuG1 antibodies, both antibodies pulled down DR5; however, only KMTR2-FuG1 interacted with furin (Fig. 4I and J).